News

The molecules include novel imaging and radiotherapeutic agents for Epstein Barr Virus (EBV) associated tumors and prostate cancer. The EBV technology, published in the October 2008 issue of

The Paragon HIS will be the foundation of the health system’s use of McKesson solutions for document management and medical imaging. New for Citrus Memorial will be a

The durability of Intermec’s CN3 ruggedized handheld computers combined with the ease-of-use of Healthwyse’s mobile clinical software and Data Capture Solutions’ support has saved customers, like Caritas Home

The patent, titled ‘Catalysts,’ US 7,651,875, was issued by the US Patent and Trademark Office (USPTO) on January 26. It covers some of the many potential applications of

Sohm said that the strategic alliance with the manufacturing house currently has a range of 85 products covering major therapeutic categories and marketing within the northern region of

Helix Medical Europe begins production this month at their newly built, 55,000 square foot facility located in Kaiserslautern, Germany. Initial manufacturing services will include custom molding of silicone

The trial investigated five ascending doses of PXS25 in 40 subjects. At all doses, PXS25 was found to be safe and well tolerated with a pharmacokinetic profile consistent

A0001 or alpha-tocopherolquinone, is a coenzyme Q analog demonstrated to improve mitochondrial function in-vitro. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England.

The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3), with LND.